Every one of those 1 sits in a single category, regulation. AIDS Drug Assistance Programs (ADAP) is most often covered alongside Gilead Sciences, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 3.1 for the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about AIDS Drug Assistance Programs (ADAP)
Every one of those 1 sits in a single category, regulation. AIDS Drug Assistance Programs (ADAP) is most often covered alongside Gilead Sciences, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 3.1 for the same window. The 6 average consequence score is below the beat benchmark of 6.3 in the same window. AIDS Drug Assistance Programs (ADAP) appears in 1 tracked Healthcare story from March 17, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 34 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering AIDS Drug Assistance Programs (ADAP). Shared-story counts are live from our verified record — not editorial picks.
Multiple states are implementing restrictive eligibility criteria and waitlists for AIDS Drug Assistance Programs (ADAPs) as rising medication costs outpace funding. These measures threaten to disrupt treatment for thousands of low-income individuals, potentially reversing years of progress in HIV viral suppression.
AIDS Drug Assistance Programs (ADAP) is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.